These findings appear to contrast with experimental results reported by Wan et al., which indicated that NEDD4-1 upregulates IGF1R (Wan et al., 2019), suggesting that NEDD4-1 may regulate IGF1R and its downstream signaling through alternative mechanisms, contributing to BC progression. Here, IGF1R is linked to breast cancer.